Novel drug-discovery approach lands big backers May 6, 2022 Auto Bot BioPharma, biopharma nl, Drug Discovery, News, Rare diseases 0 UK-based OMass Therapeutics is leaning on a proprietary form of native mass spectrometry to help develop small-molecule drugs for rare diseases.